{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:54:19Z","timestamp":1777607659430,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jad.2022.05.017","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T09:42:15Z","timestamp":1652002935000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review"],"prefix":"10.1016","volume":"311","author":[{"given":"L.","family":"Roosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sienaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.05.017_bb0005","series-title":"Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","year":"2014"},{"issue":"1\u20133","key":"10.1016\/j.jad.2022.05.017_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2008.03.029","article-title":"Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial","volume":"112","author":"Amsterdam","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1192\/bjp.bp.111.104711","article-title":"Efficacy and mood conversion rate during long-term fluoxetine v. Lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder","volume":"202","author":"Amsterdam","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.017_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2015.05.070","article-title":"Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: a randomized, double-blind, parallel-group, prospective study","volume":"185","author":"Amsterdam","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.115.169375","article-title":"Short-term venlafaxine v. Lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate","volume":"208","author":"Amsterdam","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bdi.12994","article-title":"Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study","volume":"23","author":"Antonietta Furio","year":"2021","journal-title":"Bipolar Disord."},{"issue":"1\u20132","key":"10.1016\/j.jad.2022.05.017_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0327(99)00196-2","article-title":"Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients","volume":"61","author":"Baldessarini","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpsyc.1990.01810170035006","article-title":"Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study","volume":"47","author":"Bauer","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1 Pt 2","key":"10.1016\/j.jad.2022.05.017_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1399-5618.2007.00560.x","article-title":"Rapid cycling bipolar disorder\u2013diagnostic concepts","volume":"10","author":"Bauer","year":"2008","journal-title":"Bipolar Disord."},{"issue":"11","key":"10.1016\/j.jad.2022.05.017_bb0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 study group","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry."},{"issue":"11","key":"10.1016\/j.jad.2022.05.017_bb0055","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.05.017_bb0060","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.4088\/JCP.13r08905","article-title":"Rapid cycling in bipolar disorder: a systematic review","volume":"75","author":"Carvalho","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2022.05.017_bb0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00023210-200519070-00001","article-title":"Rapid cycling bipolar disorder: clinical characteristics and treatment options","volume":"19","author":"Coryell","year":"2005","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.jad.2022.05.017_bb0070","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archpsyc.60.9.914","article-title":"The long-term course of rapid-cycling bipolar disorder","volume":"60","author":"Coryell","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4 Pt 2","key":"10.1016\/j.jad.2022.05.017_bb0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/15622970701806192","article-title":"Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute and maintenance efficacy","volume":"10","author":"Dell'osso","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2022.05.017_bb0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","article-title":"Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder","volume":"58","author":"Denicoff","year":"1997","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"10.1016\/j.jad.2022.05.017_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archpsyc.1974.01760080077013","article-title":"Clinical factors in lithium carbonate prophylaxis failure","volume":"30","author":"Dunner","year":"1974","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.017_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jad.2015.04.054","article-title":"Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial","volume":"184","author":"El-Mallakh","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.017_bb0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jad.2015.04.054","article-title":"Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial","volume":"184","author":"El-Mallakh","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.017_bb0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2021.10.003","article-title":"Lithium treatment of bipolar disorder in adults: a systematic review of randomized trials and meta-analyses","volume":"54","author":"Fountoulakis","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jad.2022.05.017_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2008.12.005","article-title":"Suicide risk in rapid cycling bipolar patients","volume":"117","author":"Garcia-Amador","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4088\/JCP.08m04909gre","article-title":"Antidepressant discontinuation in bipolar depression: a systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety","volume":"71","author":"Ghaemi","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2022.05.017_bb0115","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13136","article-title":"Citalopram for acute and preventive efficacy in bipolar depression (CAPE-BD): a randomized, double-blind, placebo-controlled trial","volume":"82","author":"Ghaemi","year":"2021","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"10.1016\/j.jad.2022.05.017_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsych.2006.12.031","article-title":"Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder","volume":"63","author":"Goldberg","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004714-200210000-00002","article-title":"Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine","volume":"22","author":"Gonzalez-Pinto","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1399-5618.2008.00587.x","article-title":"Rapid cycling bipolar disorders in primary and tertiary care treated patients","volume":"10","author":"Hajek","year":"2008","journal-title":"Bipolar Disord."},{"issue":"9","key":"10.1016\/j.jad.2022.05.017_bb0135","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0140","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J. Clin. Psychiatry."},{"issue":"10","key":"10.1016\/j.jad.2022.05.017_bb0145","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2022.05.017_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4088\/JCP.07m04022","article-title":"A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence","volume":"70","author":"Kemp","year":"2009","journal-title":"J Clin Psychiatry."},{"issue":"7","key":"10.1016\/j.jad.2022.05.017_bb0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/bdi.12013","article-title":"Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder","volume":"14","author":"Kemp","year":"2012","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0160","first-page":"268","article-title":"The role of clozapine as a mood regulator in the treatment of rapid cycling bipolar affective disorder","volume":"30","author":"K\u0131l\u0131n\u00e7el","year":"2019","journal-title":"Turk Psikiyatri Derg."},{"issue":"3","key":"10.1016\/j.jad.2022.05.017_bb0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1192\/bjp.168.3.314","article-title":"Ultra-rapid and ultradian cycling in bipolar affective illness","volume":"168","author":"Kramlinger","year":"1996","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2022.05.017_bb0170","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4088\/JCP.v64n1213","article-title":"Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies","volume":"64","author":"Kupka","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2022.05.017_bb0175","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/appi.ajp.162.7.1273","article-title":"Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients","volume":"162","author":"Kupka","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0180","first-page":"705","article-title":"Light therapy in patients with rapid cycling bipolar disorder: preliminary results","volume":"31","author":"Leibenluft","year":"1995","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.jad.2022.05.017_bb0185","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/acps.12557","article-title":"Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk","volume":"133","author":"Lorenzo-Luaces","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.jad.2022.05.017_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v69n0203","article-title":"A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"10.1016\/j.jad.2022.05.017_bb0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCT.0b013e3181dbf797","article-title":"Effectiveness of maintenance electroconvulsive therapy in rapid-cycling bipolar disorder","volume":"27","author":"Minnai","year":"2011","journal-title":"J ECT."},{"issue":"6","key":"10.1016\/j.jad.2022.05.017_bb0200","article-title":"Electroconvulsive therapy (ECT) in bipolar disorder patients with ultra-rapid cycling and unstable mixed states","volume":"57","author":"Mosolov","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1742-1241.2008.01735.x","article-title":"Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study","volume":"62","author":"Muzina","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jad.2022.05.017_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-0327(93)90083-V","article-title":"Therapy and prevention of affective illness by total sleep deprivation","volume":"27","author":"Papadimitriou","year":"1993","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.017_bb0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline","volume":"189","author":"Post","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.pra.0000290667.02484.3d","article-title":"Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study","volume":"13","author":"Reilly-Harrington","year":"2007","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2022.05.017_bb0225","first-page":"93","article-title":"Rapid Cycling in bipolar disorder: subtype or prototype?","author":"RWK","year":"2005","journal-title":"Tijdschr. Psychiatr."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jad.2022.05.017_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0327(02)00334-8","article-title":"Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling","volume":"73","author":"Sanger","year":"2003","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.jad.2022.05.017_bb0240","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1176\/ajp.161.10.1902","article-title":"Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the systematic treatment enhancement program","volume":"161","author":"Schneck","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jad.2022.05.017_bb0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jad.2005.07.011","article-title":"Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data","volume":"89","author":"Suppes","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.jad.2022.05.017_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2007.08.015","article-title":"Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder","volume":"107","author":"Suppes","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.017_bb0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2021.03.005","article-title":"Registry-based studies: what they can tell us, and what they cannot","volume":"45","author":"Taipale","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0260","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH study group","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.05.017_bb0265","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2022.05.017_bb0270","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.017_bb0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euroneuro.2021.03.008","article-title":"Bipolar disorder cohort studies: crucial, but underfunded","volume":"47","author":"Vieta","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0280","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-5618.2007.00479.x","article-title":"Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study","volume":"9","author":"Vieta E","year":"2007","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.jad.2022.05.017_bb0285","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00004714-199804000-00012","article-title":"Treatment of refractory rapid cycling bipolar disorder with risperidone","volume":"18","author":"Vieta","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2022.05.017_bb0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1399-5618.2002.01204.x","article-title":"Quetiapine in the treatment of rapid cycling bipolar disorder","volume":"4","author":"Vieta","year":"2002","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-5618.2007.00479.x","article-title":"Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study","volume":"9","author":"Vieta","year":"2007","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1399-5618.2000.020408.x","article-title":"An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization","volume":"2","author":"Walden","year":"2000","journal-title":"Bipolar Disord."},{"issue":"7","key":"10.1016\/j.jad.2022.05.017_bb0305","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bdi.12657","article-title":"Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: a double-blind placebo-controlled trial of levothyroxine (L-T","volume":"20","author":"Walshaw","year":"2018","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jad.2022.05.017_bb0310","first-page":"5","article-title":"Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study","volume":"43","author":"Wang","year":"2010","journal-title":"Psychopharmacol. Bull."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722005195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722005195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:17:43Z","timestamp":1753449463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722005195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":62,"alternative-id":["S0165032722005195"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.05.017","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}